Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
doi: https://doi.org/10.1101/2020.05.04.20090027
E Tuaillon
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
K Bolloré
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
A Pisoni
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
S Debiesse
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
C Renault
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
S Marie
3Montpellier University Hospital, Montpellier, France
S Groc
3Montpellier University Hospital, Montpellier, France
C Niels
3Montpellier University Hospital, Montpellier, France
N Pansu
3Montpellier University Hospital, Montpellier, France
AM Dupuy
3Montpellier University Hospital, Montpellier, France
D Morquin
3Montpellier University Hospital, Montpellier, France
V Foulongne
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
A Bourdin
3Montpellier University Hospital, Montpellier, France
V Le Moing
3Montpellier University Hospital, Montpellier, France
P Van de Perre
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France

Data Availability
Not available
Posted May 27, 2020.
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Subject Area
Subject Areas
- Addiction Medicine (229)
- Allergy and Immunology (507)
- Anesthesia (111)
- Cardiovascular Medicine (1253)
- Dermatology (147)
- Emergency Medicine (283)
- Epidemiology (10037)
- Gastroenterology (500)
- Genetic and Genomic Medicine (2470)
- Geriatric Medicine (239)
- Health Economics (482)
- Health Informatics (1649)
- Health Policy (756)
- Hematology (250)
- HIV/AIDS (536)
- Medical Education (255)
- Medical Ethics (75)
- Nephrology (269)
- Neurology (2295)
- Nursing (140)
- Nutrition (354)
- Oncology (1254)
- Ophthalmology (377)
- Orthopedics (134)
- Otolaryngology (226)
- Pain Medicine (158)
- Palliative Medicine (50)
- Pathology (326)
- Pediatrics (736)
- Primary Care Research (282)
- Public and Global Health (4848)
- Radiology and Imaging (844)
- Respiratory Medicine (652)
- Rheumatology (287)
- Sports Medicine (227)
- Surgery (271)
- Toxicology (44)
- Transplantation (128)
- Urology (99)